CompletedNCT04433520

Trevisio Post-Approval Study

Studying Interatrial communication

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Abbott Medical Devices
Principal Investigator
Barathi Sethuraman
DVP Global Clinical Affairs Structural Heart
Intervention
Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer PFO Occluder, ASO or Amplatzer Cribriform Occluder(device)
Enrollment
254 enrolled
Eligibility
All sexes
Timeline
20202023

Study locations (22)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04433520 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication

← Back to all trials